Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Alzheimer's disease (AD) research has entered a new era with the recent positive phase 3 clinical trials of the amyloid-beta (Aß, Abeta) antibody lecanemab.
The amyloid-beta (Aß, Abeta) antibody lecanemab demonstrated significant beneficial effects on multiple clinical and biomarker endpoints.
see also:
Immunotherapy & Alzheimer's Disease (AD)
…